AllianceBernstein’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.5M Buy
4,316,272
+1,604,829
+59% +$23M 0.02% 542
2025
Q4
$38.6M Buy
2,711,443
+2,349,014
+648% +$23.1M 0.01% 707
2025
Q3
$2.86M Hold
362,429
﹤0.01% 1801
2025
Q2
$2.08M Hold
362,429
﹤0.01% 1912
2025
Q1
$2.96M Hold
362,429
﹤0.01% 1696
2024
Q4
$3.41M Sell
362,429
-6,800
-2% -$70.7K ﹤0.01% 1677
2024
Q3
$3.94M Buy
369,229
+25,000
+7% +$272K ﹤0.01% 1626
2024
Q2
$3.41M Buy
344,229
+21,870
+7% +$224K ﹤0.01% 1657
2024
Q1
$3.8M Sell
322,359
-17,990
-5% -$230K ﹤0.01% 1578
2023
Q4
$4.83M Buy
340,349
+3,000
+0.9% +$34.1K ﹤0.01% 1510
2023
Q3
$4.1M Sell
337,349
-30
-0% -$387 ﹤0.01% 1507
2023
Q2
$4.24M Buy
337,379
+21,420
+7% +$254K ﹤0.01% 1500
2023
Q1
$3.5M Buy
315,959
+30
+0% +$370 ﹤0.01% 1552
2022
Q4
$3.86M Buy
315,929
+1,200
+0.4% +$13.5K ﹤0.01% 1551
2022
Q3
$3.29M Sell
314,729
-421,536
-57% -$4.7M ﹤0.01% 1594
2022
Q2
$7.91M Buy
736,265
+54,420
+8% +$448K ﹤0.01% 1223
2022
Q1
$6.46M Sell
681,845
-39,380
-5% -$369K ﹤0.01% 1464
2021
Q4
$8.33M Sell
721,225
-17,423
-2% -$194K ﹤0.01% 1343
2021
Q3
$7.05M Buy
738,648
+359,248
+95% +$3.67M ﹤0.01% 1425
2021
Q2
$3.66M Sell
379,400
-3,700
-1% -$36.1K ﹤0.01% 1812
2021
Q1
$3.79M Sell
383,100
-141,266
-27% -$2.19M ﹤0.01% 1724
2020
Q4
$12.1M Hold
524,366
0.01% 1041
2020
Q3
$7.4M Sell
524,366
-60,470
-10% -$881K ﹤0.01% 1147
2020
Q2
$8.82M Buy
584,836
+226,800
+63% +$2.76M 0.01% 1054
2020
Q1
$3.31M Sell
358,036
-173,467
-33% -$1.65M ﹤0.01% 1387
2019
Q4
$5.18M Buy
531,503
+211,367
+66% +$1.93M ﹤0.01% 1415
2019
Q3
$2.57M Hold
320,136
﹤0.01% 1778
2019
Q2
$4M Buy
320,136
+51,300
+19% +$651K ﹤0.01% 1561
2019
Q1
$3.66M Sell
268,836
-246,000
-48% -$3M ﹤0.01% 1554
2018
Q4
$4.93M Buy
514,836
+248,500
+93% +$2.73M ﹤0.01% 1306
2018
Q3
$3.22M Hold
266,336
﹤0.01% 1598
2018
Q2
$4.16M Buy
266,336
+46,200
+21% +$698K ﹤0.01% 1366
2018
Q1
$3.31M Sell
220,136
-36,710
-14% -$559K ﹤0.01% 1475
2017
Q4
$3.7M Sell
256,846
-80,980
-24% -$1.11M ﹤0.01% 1413
2017
Q3
$5.09M Buy
337,826
+131,990
+64% +$1.75M ﹤0.01% 1198
2017
Q2
$2.07M Buy
205,836
+28,800
+16% +$232K ﹤0.01% 1819
2017
Q1
$1.26M Sell
177,036
-1,627,186
-90% -$10.3M ﹤0.01% 2123
2016
Q4
$8.97M Sell
1,804,222
-40,307
-2% -$279K 0.01% 954
2016
Q3
$13.7M Sell
1,844,529
-257,713
-12% -$1.74M 0.01% 826
2016
Q2
$11.5M Buy
2,102,242
+324,091
+18% +$2.27M 0.01% 850
2016
Q1
$15M Sell
1,778,151
-414,823
-19% -$2.94M 0.01% 779
2015
Q4
$21.3M Buy
2,192,974
+212,897
+11% +$1.92M 0.02% 680
2015
Q3
$27.7M Buy
1,980,077
+1,822,277
+1,155% +$28.6M 0.02% 588
2015
Q2
$2.23M Buy
157,800
+154,100
+4,165% +$1.85M ﹤0.01% 1694
2015
Q1
$40K Hold
3,700
﹤0.01% 3158
2014
Q4
$31K Buy
+3,700
New +$25.4K ﹤0.01% 3164
2014
Q2
Sell
-78,565
Closed -$163K 3488
2014
Q1
$163K Sell
78,565
-3,700
-4% -$9.25K ﹤0.01% 2836
2013
Q4
$193K Sell
82,265
-13,400
-14% -$29.4K ﹤0.01% 2793
2013
Q3
$222K Sell
95,665
-1,526
-2% -$3.83K ﹤0.01% 2823
2013
Q2
$226K Buy
+97,191
New +$299K ﹤0.01% 2808

Other funds holding FOLD

AllianceBernstein's FOLD Position: Q1 2026 in Review

AllianceBernstein increased its Amicus Therapeutics (FOLD) stake by 59% in Q1 2026, buying an estimated $23M and bringing the position to 4,316,272 shares worth $61.5M. The position accounts for 0.02% of the portfolio, ranked #542.

AllianceBernstein first reported a position in FOLD in Q2 2013 and has held it in 50 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • AllianceBernstein held 4,316,272 shares of Amicus Therapeutics worth $61.5M as of Q1 2026.
  • AllianceBernstein bought 1,604,829 Amicus Therapeutics shares in Q1 2026, an estimated $23M.
  • Amicus Therapeutics made up 0.02% of AllianceBernstein's portfolio in Q1 2026, its #542 holding.
  • AllianceBernstein first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 50 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.